vs

Side-by-side financial comparison of Enovis CORP (ENOV) and Childrens Place, Inc. (PLCE). Click either name above to swap in a different company.

Enovis CORP is the larger business by last-quarter revenue ($548.9M vs $339.5M, roughly 1.6× Childrens Place, Inc.). Childrens Place, Inc. runs the higher net margin — -1.3% vs -104.1%, a 102.8% gap on every dollar of revenue. On growth, Enovis CORP posted the faster year-over-year revenue change (-2.2% vs -13.0%). Enovis CORP produced more free cash flow last quarter ($29.1M vs $-3.4M). Over the past eight quarters, Enovis CORP's revenue compounded faster (9.8% CAGR vs -13.6%).

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

The Children’s Place is a retailer of clothing for children. It sells its products primarily under its proprietary brands The Children’s Place, Gymboree, Sugar & Jade, PJ Place and Crazy 8. The company has about 525 stores in the U.S., Canada and Puerto Rico, and also sells via two online outlets and through five franchise partners in 15 countries. Its product line includes tops, skirts, dresses, jackets, shoes, bottoms, sleepwear and backpacks. The Children’s Place is headquartered in Secauc...

ENOV vs PLCE — Head-to-Head

Bigger by revenue
ENOV
ENOV
1.6× larger
ENOV
$548.9M
$339.5M
PLCE
Growing faster (revenue YoY)
ENOV
ENOV
+10.8% gap
ENOV
-2.2%
-13.0%
PLCE
Higher net margin
PLCE
PLCE
102.8% more per $
PLCE
-1.3%
-104.1%
ENOV
More free cash flow
ENOV
ENOV
$32.5M more FCF
ENOV
$29.1M
$-3.4M
PLCE
Faster 2-yr revenue CAGR
ENOV
ENOV
Annualised
ENOV
9.8%
-13.6%
PLCE

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
ENOV
ENOV
PLCE
PLCE
Revenue
$548.9M
$339.5M
Net Profit
$-571.1M
$-4.3M
Gross Margin
59.9%
33.1%
Operating Margin
-101.7%
1.1%
Net Margin
-104.1%
-1.3%
Revenue YoY
-2.2%
-13.0%
Net Profit YoY
18.8%
-121.5%
EPS (diluted)
$-9.99
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENOV
ENOV
PLCE
PLCE
Q4 25
$548.9M
$339.5M
Q3 25
$564.5M
$298.0M
Q2 25
$558.8M
$242.1M
Q1 25
$408.6M
Q4 24
$561.0M
$390.2M
Q3 24
$505.2M
$319.7M
Q2 24
$525.2M
$267.9M
Q1 24
$516.3M
$455.0M
Net Profit
ENOV
ENOV
PLCE
PLCE
Q4 25
$-571.1M
$-4.3M
Q3 25
$-36.7M
$-5.4M
Q2 25
$-56.0M
$-34.0M
Q1 25
$-8.0M
Q4 24
$-703.2M
$20.1M
Q3 24
$-31.5M
$-32.1M
Q2 24
$-18.6M
$-37.8M
Q1 24
$-72.0M
$-128.8M
Gross Margin
ENOV
ENOV
PLCE
PLCE
Q4 25
59.9%
33.1%
Q3 25
59.3%
34.0%
Q2 25
59.5%
29.2%
Q1 25
28.5%
Q4 24
54.8%
35.5%
Q3 24
56.7%
35.0%
Q2 24
55.0%
34.6%
Q1 24
57.7%
21.8%
Operating Margin
ENOV
ENOV
PLCE
PLCE
Q4 25
-101.7%
1.1%
Q3 25
-3.0%
1.4%
Q2 25
-8.4%
-10.0%
Q1 25
1.7%
Q4 24
-118.5%
7.5%
Q3 24
-6.3%
-6.8%
Q2 24
-8.4%
-10.4%
Q1 24
-6.8%
-13.6%
Net Margin
ENOV
ENOV
PLCE
PLCE
Q4 25
-104.1%
-1.3%
Q3 25
-6.5%
-1.8%
Q2 25
-10.0%
-14.1%
Q1 25
-2.0%
Q4 24
-125.4%
5.1%
Q3 24
-6.2%
-10.0%
Q2 24
-3.5%
-14.1%
Q1 24
-13.9%
-28.3%
EPS (diluted)
ENOV
ENOV
PLCE
PLCE
Q4 25
$-9.99
$-0.19
Q3 25
$-0.64
$-0.24
Q2 25
$-0.98
$-1.57
Q1 25
$-0.60
Q4 24
$-12.69
$1.57
Q3 24
$-0.58
$-2.51
Q2 24
$-0.34
$-2.98
Q1 24
$-1.32
$-10.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENOV
ENOV
PLCE
PLCE
Cash + ST InvestmentsLiquidity on hand
$33.6M
$7.3M
Total DebtLower is stronger
$1.4B
$107.4M
Stockholders' EquityBook value
$2.0B
$-8.6M
Total Assets
$4.4B
$762.5M
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENOV
ENOV
PLCE
PLCE
Q4 25
$33.6M
$7.3M
Q3 25
$44.1M
$7.8M
Q2 25
$38.5M
$5.7M
Q1 25
$5.3M
Q4 24
$48.2M
$5.7M
Q3 24
$35.4M
$9.6M
Q2 24
$35.0M
$13.0M
Q1 24
$66.3M
$13.6M
Total Debt
ENOV
ENOV
PLCE
PLCE
Q4 25
$1.4B
$107.4M
Q3 25
$1.4B
$107.2M
Q2 25
$1.4B
$107.0M
Q1 25
$166.0M
Q4 24
$1.3B
$165.7M
Q3 24
$1.3B
$165.4M
Q2 24
$1.3B
$166.6M
Q1 24
$1.3B
$49.8M
Stockholders' Equity
ENOV
ENOV
PLCE
PLCE
Q4 25
$2.0B
$-8.6M
Q3 25
$2.6B
$-4.9M
Q2 25
$2.6B
$1.4M
Q1 25
$-59.4M
Q4 24
$2.6B
$-49.6M
Q3 24
$3.3B
$-68.9M
Q2 24
$3.3B
$-34.9M
Q1 24
$3.3B
$-9.0M
Total Assets
ENOV
ENOV
PLCE
PLCE
Q4 25
$4.4B
$762.5M
Q3 25
$5.0B
$805.1M
Q2 25
$4.9B
$779.6M
Q1 25
$747.6M
Q4 24
$4.7B
$888.8M
Q3 24
$5.6B
$921.4M
Q2 24
$5.4B
$848.3M
Q1 24
$5.5B
$800.3M
Debt / Equity
ENOV
ENOV
PLCE
PLCE
Q4 25
0.67×
Q3 25
0.54×
Q2 25
0.53×
75.63×
Q1 25
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENOV
ENOV
PLCE
PLCE
Operating Cash FlowLast quarter
$82.6M
$6.2M
Free Cash FlowOCF − Capex
$29.1M
$-3.4M
FCF MarginFCF / Revenue
5.3%
-1.0%
Capex IntensityCapex / Revenue
9.7%
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$22.8M
$39.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENOV
ENOV
PLCE
PLCE
Q4 25
$82.6M
$6.2M
Q3 25
$47.8M
$-30.5M
Q2 25
$-1.6M
$-43.0M
Q1 25
$121.3M
Q4 24
$88.3M
$-44.2M
Q3 24
$53.6M
$-83.9M
Q2 24
$7.8M
$-110.8M
Q1 24
$-36.2M
$135.4M
Free Cash Flow
ENOV
ENOV
PLCE
PLCE
Q4 25
$29.1M
$-3.4M
Q3 25
$3.4M
$-31.9M
Q2 25
$-44.9M
$-46.4M
Q1 25
$121.2M
Q4 24
$35.1M
$-47.7M
Q3 24
$2.4M
$-91.7M
Q2 24
$-31.6M
$-115.5M
Q1 24
$-73.1M
$132.2M
FCF Margin
ENOV
ENOV
PLCE
PLCE
Q4 25
5.3%
-1.0%
Q3 25
0.6%
-10.7%
Q2 25
-8.0%
-19.2%
Q1 25
29.7%
Q4 24
6.3%
-12.2%
Q3 24
0.5%
-28.7%
Q2 24
-6.0%
-43.1%
Q1 24
-14.2%
29.1%
Capex Intensity
ENOV
ENOV
PLCE
PLCE
Q4 25
9.7%
2.8%
Q3 25
7.9%
0.5%
Q2 25
7.7%
1.4%
Q1 25
0.0%
Q4 24
9.5%
0.9%
Q3 24
10.1%
2.4%
Q2 24
7.5%
1.8%
Q1 24
7.2%
0.7%
Cash Conversion
ENOV
ENOV
PLCE
PLCE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-2.20×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

PLCE
PLCE

The Childrens Place US$307.4M91%
The Childrens Place International$32.1M9%
Gift Cards$1.7M1%

Related Comparisons